Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.13
+0.25 (3.63%)
Mar 16, 2026, 4:00 PM EDT - Market closed
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $8.7 million as of March 16, 2026. Its market cap has increased by 31.65% in one year.
Market Cap
8.70M
Enterprise Value
5.70M
1-Year Change
31.65%
Ranking
Category
Stock Price
$7.13
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $8.70M, a decrease of -97.31%. That is a compound annual growth rate of -17.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 6.64M | -18.68% |
| Dec 30, 2025 | 8.17M | 31.74% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 9.23M |
| Imunon | 9.18M |
| Iterum Therapeutics | 9.11M |
| TransCode Therapeutics | 8.97M |
| Cardio Diagnostics Holdings | 8.29M |
| Akari Therapeutics, | 8.19M |
| Theriva Biologics | 8.04M |
| Artelo Biosciences | 7.99M |